- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Hemogenyx Pharmaceuticals PLC (HEMO)
Hemogenyx Pharmaceuticals PLC stock price live, this page displays LON HEMO stock exchange data. View the HEMO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Hemogenyx Pharmaceuticals PLC real time stock price chart below.
What Is the Hemogenyx Pharmaceuticals PLC Stock Price Today?
The Hemogenyx Pharmaceuticals PLC stock price today is 137.750.
What Is the Stock Symbol for Hemogenyx Pharmaceuticals PLC?
The stock symbol for Hemogenyx Pharmaceuticals PLC is ""HEMO.""
What Stock Exchange Does Hemogenyx Pharmaceuticals PLC Trade On?
Hemogenyx Pharmaceuticals PLC is listed and trades on the London stock exchange.
Is Hemogenyx Pharmaceuticals PLC a Good Stock to Buy?
Determining whether Hemogenyx Pharmaceuticals PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HEMO quote. (ISIN: GB00BQVXM815)
What Is the Hemogenyx Pharmaceuticals PLC Stock Price Today?
The Hemogenyx Pharmaceuticals PLC stock price today is 137.750.
What Is the Stock Symbol for Hemogenyx Pharmaceuticals PLC?
The stock symbol for Hemogenyx Pharmaceuticals PLC is ""HEMO.""
What Stock Exchange Does Hemogenyx Pharmaceuticals PLC Trade On?
Hemogenyx Pharmaceuticals PLC is listed and trades on the London stock exchange.
Is Hemogenyx Pharmaceuticals PLC a Good Stock to Buy?
Determining whether Hemogenyx Pharmaceuticals PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HEMO quote. (ISIN: GB00BQVXM815)
London
Currency in GBP
137.750
+2.250(+1.66%)
Closed·
Fair Value
An estimate of a Hemogenyx Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
133.045
141.500
52 wk Range
124.500
1,199.960
HEMO Scorecard
Full Analysis
Quickly burning through cash
HEMO is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Hemogenyx Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
133.045141.500
52 wk Range
124.5001,199.960
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
HEMO Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Hemogenyx Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell
Hemogenyx Pharmaceuticals PLC Company Profile
Hemogenyx Pharmaceuticals Plc, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of treatments for blood cancer. The company’s lead product candidate is the HG-CT-1 therapy for the treatment of relapsed or refractory acute myeloid leukemia. It also develops chimeric bait receptor to treat viral infections derived and for certain cancer and neurological conditions; and CDX bi-specific antibody which eliminates hematopoietic stem cells/hematopoietic progenitors in a patient using bi-specific antibodies; and therapies for the improvement of bone marrow and blood stem cell transplant procedures. Hemogenyx Pharmaceuticals Plc was incorporated in 2013 and is headquartered in London, the United Kingdom.
Compare HEMO to Peers and Sector
Metrics to compare | HEMO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHEMOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.1x | −6.0x | −0.5x | |
PEG Ratio | −0.04 | −0.06 | 0.00 | |
Price/Book | 7.0x | 4.6x | 2.6x | |
Price / LTM Sales | - | 13.8x | 3.3x | |
Upside (Analyst Target) | - | 88.9% | 41.6% | |
Fair Value Upside | Unlock | −19.0% | 5.9% | Unlock |
Earnings
Latest Release
Apr 25, 2025
EPS / Forecast
-0.79 / --
Revenue / Forecast
-- / --
FAQ
What Stock Exchange Does Hemogenyx Pharma Trade On?
Hemogenyx Pharma is listed and trades on the London Stock Exchange stock exchange.
What Is the Stock Symbol for Hemogenyx Pharma?
The stock symbol for Hemogenyx Pharma is "HEMO."
What Is the Hemogenyx Pharma Market Cap?
As of today, Hemogenyx Pharma market cap is 6.37M.
What Is Hemogenyx Pharma's Earnings Per Share (TTM)?
The Hemogenyx Pharma EPS (TTM) is -1.70.
From a Technical Analysis Perspective, Is HEMO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Hemogenyx Pharma Stock Split?
Hemogenyx Pharma has split 1 times.
How Many Employees Does Hemogenyx Pharma Have?
Hemogenyx Pharma has 16 employees.
What is the current trading status of Hemogenyx Pharma (HEMO)?
As of 13 Aug 2025, Hemogenyx Pharma (HEMO) is trading at a price of 137.75, with a previous close of 135.50. The stock has fluctuated within a day range of 133.05 to 141.50, while its 52-week range spans from 124.50 to 1,199.96.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.